Top Kidney & Urology Procedures at KIMS Secunderabad for International Patients

1. Kidney Transplant — Living Donor

The most common procedure sought by international patients at KIMS. A living related or living unrelated donor kidney transplant, performed by the KIMS transplant surgery and nephrology team with 1,500+ transplants of institutional experience. Living donor transplant provides superior outcomes to deceased donor — 5-year graft survival above 85 to 90% at experienced centres. Pre-transplant teleconsultation covers: donor-recipient evaluation, crossmatch and HLA typing logistics, and the surgical and post-operative timeline.

KIMS differentiator: 1,500+ transplants including ABO-incompatible and swap transplants. NOTTO registered. Same DM Nephrology-qualified nephrologist from pre-transplant through lifelong post-transplant monitoring.

2. ABO-Incompatible Kidney Transplant

For patients who have a willing living donor but whose blood groups do not match — under standard protocols, an O-positive recipient cannot receive from an A-positive donor, for example. The ABO-incompatible transplant protocol at KIMS uses rituximab (to deplete antibody-producing B-cells) and plasmapheresis (to remove existing blood group antibodies) to reduce the antibody titre to a safe threshold before transplant. The surgical procedure is then identical to a compatible transplant. Graft survival approaches that of compatible transplants at experienced centres.

This is one of the most clinically significant offerings for international patients — because ABO-incompatible transplant is available at relatively few centres globally. Patients told that their family donor's blood group mismatch permanently excludes living donor transplant should enquire specifically about this programme at KIMS before accepting that conclusion.

KIMS differentiator: Established protocol, repeated cases, experienced team. Most Indian hospital chains cannot offer this — KIMS has performed multiple ABO-incompatible transplants with outcomes comparable to compatible transplants.

3. TULSA-PRO — Prostate Cancer and BPH

TULSA-PRO (Transurethral Ultrasound Ablation) is an MRI-guided, incision-free prostate cancer and BPH treatment — FDA-cleared, available in India exclusively at KIMS Secunderabad. No incision, no radiation, no general anaesthesia required in most cases, same-day or next-morning discharge. Pivotal trial outcomes: 95% PSA reduction at 1 year, 93% of patients pad-free, significantly better ejaculation preservation than surgery or radiation.

International patients specifically seek TULSA-PRO at KIMS because it is not available in their home countries, or because waiting lists for the procedure in the USA or Europe are long. The pre-travel teleconsultation includes a review of the prostate MRI and biopsy reports to confirm TULSA-PRO candidacy before the patient travels.

KIMS differentiator: India's first and only TULSA-PRO centre. No other hospital in India offers this.

4. Robotic Radical Prostatectomy (RARP) — Prostate Cancer

Robotic-assisted laparoscopic radical prostatectomy using the Da Vinci Xi and X platforms. Nerve-sparing technique for optimal erectile function preservation. 10x magnified 3D vision, 7-degree instrument freedom. 2 to 3 night hospital stay, catheter removal at 7 days, return to normal activity within 4 to 6 weeks. Cancer control equivalent to open prostatectomy with significantly better functional outcomes and recovery profile.

KIMS differentiator: Da Vinci Xi AND X — both platforms. Dr. Likhiteswer Pallagani: Vattikuti Foundation Fellowship in Uro-Oncology and Robotic Surgery, 400+ robotic surgeries. MDT review of every case.

5. HoLEP — Laser Prostate Surgery for BPH

Holmium Laser Enucleation of the Prostate — the gold standard for BPH surgery, with the lowest retreatment rate of any prostate surgical procedure (under 2% at 5 years). KIMS performs HoLEP with 100W Holmium laser on glands of any size — including very large glands (above 150cc) that other centres decline for endoscopic surgery and refer for open prostatectomy. Catheter removal at 24 hours, 1 to 2 night stay.

KIMS differentiator: No prostate size limit — HoLEP at KIMS treats glands that would require open surgery elsewhere. Under 2% retreatment rate at 5 years.

6. Kidney Stone Surgery — RIRS and Mini-PCNL

KIMS was the pioneer of PCNL in India — the first hospital to perform percutaneous nephrolithotomy as standard treatment. Today, KIMS offers the full range: RIRS (flexible ureteroscopy with Holmium and Thulium Fiber Laser — day-care, no skin incision) and Mini-PCNL (4.8Fr ultra-mini to standard 30Fr — for larger or harder stones). CT Hounsfield Unit measurement guides laser selection and access size for each stone. For complex staghorn stones, bilateral stones, or stones in anatomically unusual kidneys — including transplanted kidneys — the KIMS stone team has managed cases most centres have not seen.

KIMS differentiator: Pioneer PCNL experience. Dual Holmium + TFL laser. Full access size range. Metabolic stone clinic for recurrence prevention after surgery.

7. Kidney Biopsy with Full NABL Pathology — Second Opinion

For patients with unexplained proteinuria, haematuria, nephrotic syndrome, or rapidly progressive kidney disease who have been told that biopsy elsewhere was inconclusive or incomplete — KIMS's NABL-accredited laboratory performs the full three-component biopsy workup (light microscopy, immunofluorescence, and electron microscopy) in-house. EM is not available at many Indian diagnostic centres. International patients seeking a second opinion on a complex glomerular disease diagnosis can have the KIMS biopsy report reviewed by Dr. Aswini Dutt T, whose subspecialty focus is glomerular disease.

KIMS differentiator: LM + IF + EM in-house. Same-day biopsy procedure with 5 to 7 working day full report. Dr. Aswini Dutt T — glomerular disease subspecialty.